NEW YORK, Jan. 4, 2012 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company with a focus on cell-based therapeutic development, today announced that the Company and Progenitor Cell Therapy ("PCT"), will be presenting at four upcoming January conferences: Biotech Showcase 2012, BOCEMb 2012 - Noble Financial Capital Markets Equity Conference, ECI's Inaugural Scale-Up and Manufacturing of Cell-Based Therapies, and Phacilitate's Cell & Gene Therapy Forum 2012.
Dr. Robin L. Smith commented, "This list of January events demonstrates our widespread involvement in various industry forums and investor conferences that give us the opportunity to highlight our cell therapy industry expertise designed to put us at the forefront in transforming chronic disease through the application of cell based medicine while strategically providing revenues from our contract cGMP manufacturing of a variety of product candidates under development."
Biotech Showcase 2012 – January 10, 2012, San Francisco, California – Park 55 Wyndham8:00 – 9:30 AM – Dr. Robin L. Smith, Chairman and CEO of NeoStem, will present as part of a panel discussion entitled "Regenerative Medicine State of the Industry Briefing."
10:30 AM – Dr. Robin L. Smith, Chairman and CEO of NeoStem, will present on NeoStem in Track C.
9:30 – 11:00 AM – Dr. Andrew L. Pecora, Chief Medical Officer of NeoStem, will present on Amorcyte, a NeoStem company developing novel treatments for cardiovascular disease, as part of a panel discussion entitled "Cardiovascular, AMI and PAD—Part 1".
ECI's Inaugural Scale-Up and Manufacturing of Cell-Based Therapies– January 11-13, 2012, San Diego, California – Catamaran Resort Hotel10:40 AM on Thursday, January 12 – Dr. Robert A. Preti, President of PCT, will chair a session titled "Process Development Challenges f
|SOURCE NeoStem, Inc.|
Copyright©2010 PR Newswire.
All rights reserved